Global Transformation? Sun Pharma Names Former Teva CEO Israel Makov As Chairman
This article was originally published in PharmAsia News
Executive Summary
Experts say the Indian pharma’s strategy may be to drive high growth in RoW markets and enable a transition to professional management.